Showing results (1721-1730 of 2,567) with videos related to

Sort By:
Pageof 257
Drug Testing and Analysis|July 9, 2016
Detection of phenazepam in illicitly manufactured Erimin 5 tabletsWendy J L Lim, Angeline T W Yap, Merula Mangudi, et al.
Drug Testing and Analysis|June 25, 2016
The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studiesJune Bryan de la Peña, Jae Hoon Cheong
Drug Testing and Analysis|February 26, 2016
An LC-MS/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazinesElena Lendoiro, Cristian Jiménez-Morigosa, Angelines Cruz, et al.
Drug Testing and Analysis|February 19, 2016
Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletesRichard I G Holt, Nishan Guha, Walailuck Böhning, et al.
Drug Testing and Analysis|December 2, 2015
Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumersAdrian A Franke, Xingnan Li, Jennifer F Lai
Drug Testing and Analysis|November 6, 2015
Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013David I Johnston, Arthur Chang, Melissa Viray, et al.
Drug Testing and Analysis|October 23, 2015
Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping controlEunju Cha, Sohee Kim, Ho Jun Kim, et al.
Drug Testing and Analysis|November 13, 2015
Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysisMasato Okano, Mario Thevis, Mitsuhiko Sato, et al.
Drug Testing and Analysis|October 21, 2014
Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horsesH K Knych, R M Arthur, M M Mitchell, et al.
Drug Testing and Analysis|October 22, 2014
Determination of a selection of anti-epileptic drugs and two active metabolites in whole blood by reversed phase UPLC-MS/MS and some examples of application of the method in forensic toxicology casesRitva Karinen, Vigdis Vindenes, Inger Hasvold, et al.
Pageof 257